Area of Interest
Providing pharmacy services to the most vulnerable patient populations is a mission for many hospitals. Fortunately, it is a mission made possible by the 340B drug discount program. However, in order to achieve your goal, it is critical to navigate what can feel like an overwhelming set of tasks.
Patient identification. Dose eligibility. EMR and finance data capture. Changing legislation. Audits. Mapping charge description master. If you’re familiar with these terms, chances are you know the 340B landscape already. Your job is a balancing act — optimizing your program while reducing risk — and is likely one of the tougher challenges you’ve faced. We know. We’ve been there too.
With increasing complexity and demand for audit preparedness, it’s critical to have a partner in your corner to keep the mission alive. Whether you’re just getting started or already navigating the 340B landscape, we’re confident that we can help you make the next right move.
Keeping data – and people – healthy
Things have changed quickly and dramatically in the healthcare industry – by necessity. The Affordable Care Act has allowed millions of Americans to gain health insurance. Global health initiatives are also improving health and raising the bar for healthcare around the world.
CVS Health Research Institute Study Demonstrates Impact of Prescription Refill Programs on Medication Adherence
WOONSOCKET, R.I., Nov. 16, 2015 /PRNewswire/ — New research by the CVS Health Research Institute is the first to show the impact of prescription refill programs on medication adherence. The study, published in the American Journal of Managed Care, found that ReadyFill®, the refill program available at CVS/pharmacy®, improved adherence to medications for common chronic conditions without …
U.S. drug benefit managers clamp down on specialty pharmacies
(Reuters) — In recent days, the largest U.S. managers of private prescription drug benefits have cut off at least eight pharmacies that work closely with drugmakers, intensifying scrutiny of a system that helps inflate drug prices, officials at the pharmacy benefit managers told Reuters.
Nearly half of hepatitis C patients on medicaid denied coverage for life-saving drugs
Nearly 50 percent of Medicaid patients infected with chronic hepatitis C whose doctors had prescribed newer, life-saving antiviral drugs were denied coverage to the therapies because they weren’t considered “a medical necessity” or because the patients tested positive for alcohol/drugs, among other reasons, according to new research.
Blues of North Dakota worried about cost of specialty drugs
BISMARCK, N.D. (AP) – Prescription drugs account for 21 percent of North Dakota’s largest insurance provider’s health care spending. Following the national trend, 15 percent of that drug spending is experiencing a high inflation rate, increasing already high health care costs. “When the cost of prescription drugs increases, those costs …
CVS Health Research Institute Study Finds that Initial Prescription Fills Can Accurately Predict Long-term Medication …
WOONSOCKET, R.I., Sept. 21, 2015 /PRNewswire/ — A new study by researchers at the CVS Health (CVS) Research Institute and Brigham and Women’s Hospital provides evidence that patients’ patterns of medication fills in the first few months after starting on a chronic therapy accurately predict future medication adherence behavior. The study, published in The American Journal of Managed Care …
User-friendly yet sophisticated, 340B Architect℠ was designed to help you get the most from your program while maintaining regulatory compliance. Among the many features, it manages dispensing in hospital and retail contract pharmacy settings on one platform, automates CDM/NDC maintenance, and provides detailed NDC and patient-level tracking and audit trails. Learn More »
Whether you are just starting out with the 340B program or want to optimize your participation, our consultant experts are ready to help you better manage and enhance pharmacy services critical to your most vulnerable patients. Learn More »
- Industry News